Qube Research & Technologies LTD Biocryst Pharmaceuticals Inc Transaction History

Qube Research & Technologies LTD

$82.3 Billion
Q1 2025

A detailed history of Qube Research & Technologies LTD transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 940,665 shares of BCRX stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

940,665

Previous 272,844 244.76%

Holding current value

$10.3 Million

Previous $2.05 Million 243.93%

% of portfolio

0.01%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$7.06 - $9.39 $4.71 Million - $6.27 Million	667,821 Added 244.76%	940,665 $7.05 Million
Q4 2024 Feb 14, 2025	BUY	$7.03 - $8.43 $133,169 - $159,689	18,943 Added 7.46%	272,844 $2.05 Million
Q3 2024 Nov 14, 2024	BUY	$6.41 - $8.69 $1.63 Million - $2.21 Million	253,901 New	253,901 $1.93 Million
Q1 2024 May 14, 2024	SELL	$4.89 - $7.65 $1.77 Million - $2.76 Million	-361,109 Reduced 35.11%	667,394 $3.39 Million
Q4 2023 Feb 13, 2024	BUY	$4.98 - $6.77 $5.12 Million - $6.96 Million	1,028,503 New	1,028,503 $6.16 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $1.49 Million - $1.89 Million	214,095 New	214,095 $1.51 Million
Q3 2021 Nov 12, 2021	SELL	$14.21 - $17.65 $575,547 - $714,877	-40,503 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.5 - $17.24 $54,615 - $99,112	-5,749 Reduced 12.43%	40,503 $640,000
Q1 2021 May 14, 2021	BUY	$7.37 - $13.61 $340,877 - $629,489	46,252 New	46,252 $470,000
Q3 2020 Nov 12, 2020	SELL	$3.43 - $5.53 $757,656 - $1.22 Million	-220,891 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $419,692 - $1.24 Million	220,891 New	220,891 $1.05 Million
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $23,737 - $60,975	-14,836 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.59 - $3.45 $23,589 - $51,184	14,836 New	14,836 $51,000

Others Institutions Holding BCRX

# of Institutions

293

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $2.04B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Biocryst Pharmaceuticals Inc Transaction History